Selection and Identification of Novel Antibacterial Agents Against Planktonic Growth and Biofilm Formation of Enterococcus Faecalis.
Zhong Chen,Kun Song,Yongpeng Shang,Yanpeng Xiong,Zhihui Lyu,Junwen Chen,Jinxin Zheng,Peiyu Li,Yang Wu,Chenjian Gu,Youhua Xie,Qiwen Deng,Zhijian Yu,Jian Zhang,Di Qu
DOI: https://doi.org/10.1021/acs.jmedchem.1c00939
IF: 8.039
2021-01-01
Journal of Medicinal Chemistry
Abstract:YycFG, one of the two-component systems involved in the regulation of biofilm formation, has attracted increasing interest as a potential target of antibacterial and antibiofilm agents. YycG inhibitors for Staphylococcus aureus and Staphylococcus epidermidis have been developed, but Enterococcus faecalis remains underexplored. Herein, we selected and identified novel candidate molecules against E. faecalis targeting histidine kinase YycG using high-throughput virtual screening; six molecules (compound-16, -30, -42, -46, -59, and -62) with low cytotoxicity toward mammalian cells were verified as potential YycG inhibitors through an autophosphorylation test and binding kinetics. Compound-16 inhibited planktonic cells of E. faecalis, including the vancomycin- or linezolid-resistant strains. In contrast, compound-62 did not affect planktonic growth but significantly inhibited biofilm formation in static and dynamic conditions. Compound-62 combined with ampicillin could synergistically eradicate the biofilm-embedded viable bacteria. The study demonstrates that YycG inhibitors may be valuable approaches for the development of novel antimicrobial agents for difficult-to-treat bacterial infections.